Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Serum Institute of India Pvt. Ltd., a biotechnology company that develops and manufactures vaccines for diphtheria, tetanus, pertussis, Hib, BCG, r-hepatitis B, measles, mumps, and rubella disease.
Serum Institute Of India Private Limited, is an unlisted private company incorporated on 22 May, 1984. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 55.00 cr and the total paid-up capital is INR 4.82 cr.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
AMBIT CAPITAL PRIVATE LIMITED
No. of Loans: 1
Total Amount : 10.0 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Cyrus Soli Poonawalla
Shareholder
|
00044650 | 17 years |
Director | Zavareh Soli Poonawalla
Shareholder
|
00044760 | 41 years |
Whole-time Director | Adar Cyrus Poonawalla
Shareholder
|
00044815 | 17 years |
Kmp | Adar Cyrus Poonawalla | <HIDDEN> | 10 years |
Director | Behroze Zavareh Poonawalla | 00044877 | 39 years |
Whole-time Director | Umesh Sharadrao Shaligram | 00212458 | 4 years |
Whole-time Director | Satish Ramchandra Mundra | 00416654 | 15 years |
Whole-time Director | Natasha Adar Poonawalla | 01264082 | 8 years |
Kmp | Sunder Lata Anand Kavitkar | <HIDDEN> | 2 years |
Director | Parag Rajendra Deshmukh | 03377341 | 1 years |
Whole-time Director | Kedar Shashikant Gokhale | 08788551 | 3 years |
Whole-time Director | Sunil Gairola | 08893242 | 4 years |
Whole-time Director | Prasad Suryakant Kulkarni | 08991838 | 4 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SOVEREIGN PHARMA PRIVATE LIMITED |
Active
|
98.0 Cr | 2 | Maharashtra |
ADRUS ESTATES AND PROPERTIES PVT LTD |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
VILLOO POONAWALLA RACING & BREEDING PRIVATE LIMITED |
Active
|
44.0 Cr | 3 | Maharashtra |
GENESIS PARKS LLP |
Active
|
5.0 Cr | 2 | Maharashtra |
ADAR ESTATES LLP |
Active
|
5.0 Cr | 2 | Maharashtra |
POONAWALLA AVIATION PRIVATE LIMITED |
Active
|
1,410.3 Cr | 1 | Maharashtra |
POONAWALLA INVESTMENTS AND INDUSTRIES PRIVATE LIMITED |
Active
|
98.6 L | 2 | Maharashtra |
POONAWALLA ESTATES STUD AND AGRI FARM PRIVAE LIMITED |
Active
|
41.4 Cr | 2 | Maharashtra |
SERUM INTERNATIONAL LIMITED |
Amalgamated
|
4.1 Cr | 4 | Maharashtra |
THE POONA STUD FARM PRIVATE LIMITED |
Active
|
1.6 Cr | 2 | Maharashtra |
POONAWALLA ASTONISH STUD PRIVATE LIMITED |
Active
|
5.6 Cr | 2 | Maharashtra |
ASTONISH STUD PRIVATE LIMITED |
Amalgamated
|
24.3 L | 2 | Maharashtra |
SHELLAC TRADING PRIVATE LIMITED |
Strike Off
|
1,000.0 | 1 | Maharashtra |
ANNILNA INVESTMENT PVT LTD |
Active
|
28.0 L | 2 | Maharashtra |
SIMONE POONAWALLA CONSTRUCTIONS AND STUD PRIVATE LIMITED |
Active
|
20.3 L | 1 | Maharashtra |
INTERVALVE POONAWALLA LIMITED |
Active
|
8.8 Cr | 1 | Maharashtra |
YODELSIM HOLDINGS PVT. LTD. |
Active
|
88.5 L | 2 | Maharashtra |
SASWAD INVESTMENT PVT LTD |
Amalgamated
|
99.8 L | 1 | Maharashtra |
POONAWALLA FINVEST AND AGRO PRIVATE LIMITED |
Active
|
87.0 L | 2 | Maharashtra |
POONAWALLA FINANCIALS PRIVATE LIMITED |
Active
|
20.9 Cr | 2 | Maharashtra |
EL-O-MATIC (INDIA) PRIVATE LIMITED |
Active
|
96.8 L | 1 | Maharashtra |
CARTIER INVESTMENT PRIVATE LIMITED |
Active
|
3.5 Cr | 1 | Maharashtra |
DELNA PROPERTIES PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
POONAWALLA RACING AND BREEDING PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
POONAWALLA HOTELS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 1 | Maharashtra |
YOHAN POONAWALLA FINANCIALS PRIVATE LIMI TED |
Amalgamated
|
1.1 Cr | 2 | Maharashtra |
POONAWALLA EXHILARATION STUD PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
POONAWALLA MYSTICAL STUD PRIVATE LIMITED |
Active
|
5.0 L | 2 | Maharashtra |
POONAWALLA CONSTRUCTIONS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
18.4 Cr | 1 | Maharashtra |
EXHILARATION STUD PRIVATE LIMITED |
Converted to LLP and Dissolved
|
1.0 L | 2 | Maharashtra |
POONAWALLA REAL ESTATES AND HOTELS LLP |
Active
|
18.6 Cr | 1 | Maharashtra |
SIMONE POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
DELNA POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
DELNA PROPERTIES LLP |
Active
|
1.0 L | 2 | Maharashtra |
CYZA AGRO AND STUD FARMS LLP |
Active
|
24.9 L | 1 | Maharashtra |
POONAWALLA CONSTRUCTIONS LLP |
Active
|
18.4 Cr | 2 | Maharashtra |
CARTIER PROPERTIES LLP |
Active
|
3.5 Cr | 1 | Maharashtra |
POONAWALLA HOLDINGS LLP |
Active
|
1.4 Cr | 2 | Maharashtra |
SHELLAC PROPERTIES LLP |
Active
|
95.5 L | 1 | Maharashtra |
YOHAN POONAWALLA PROJECTS LLP |
Active
|
10.0 L | 2 | Maharashtra |
POONAWALLA STUD FARM PRIVATE LIMITED |
Active
|
5.4 L | 1 | Maharashtra |
CYZA AGRO AND STUD FARMS PRIVATE LIMITED |
Converted to LLP and Dissolved
|
24.9 L | 2 | Maharashtra |
SANOTI PROPERTIES LLP |
Active
|
10.0 Cr | 1 | Maharashtra |
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED |
Active
|
636.6 Cr | 6 | Maharashtra |
RISING SUN HOLDINGS PVT LTD |
Active
|
7,794.0 Cr | 1 | Maharashtra |
POONAWALLA FINCORP LIMITED |
Active
|
155.5 Cr | 1 | Maharashtra |
POONAWALLA FINANCE PRIVATE LIMITED |
Active
|
1,230.6 Cr | 1 | Maharashtra |
POONAWALLA CREDIT PRIVATE LIMITED |
Active
|
254.9 Cr | 1 | Maharashtra |
COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED |
Active
|
7.5 Cr | 1 | Maharashtra |
AMRON REALTORS PRIVATE LIMITED |
Active
|
107.5 Cr | 1 | Maharashtra |
SRI THAKUR BIOTECH LLP |
Active
|
50,000.0 | 1 | Maharashtra |
PHINITY DEVELOPERS PRIVATE LIMITED |
Active
|
1,061.0 Cr | 1 | Maharashtra |
KEDAR GOKHALE ADVISORY LLP |
Active
|
5,000.0 | 1 | Maharashtra |
GAIROLA BIOTECH ADVISORY LLP |
Active
|
1.0 L | 1 | Maharashtra |
PAURAS ADVISORY LLP |
Active
|
50,000.0 | 1 | Maharashtra |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SERUM INTERNATIONAL B.V. | Netherlands | - | - |
Bilthoven Biologicals B.V. | Netherlands | - | - |
SERUM INSTITUTE INC | United States | - | - |
Serum Life Science Europe Gmbh | Germany | - | - |
SEZ BIOTECH SERVICES PRIVATE LIMITED | Maharashtra | 2006 | ₹ 1,250.4 Cr |
POONAWALLA AVIATION PRIVATE LIMITED | Maharashtra | 2005 | ₹ 1,410.3 Cr |
Serum Life Sciences B.V | Netherlands | - | - |
Serum AMR Products B.V. | Netherlands | - | - |
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED | Maharashtra | 2020 | ₹ 636.6 Cr |
Serum Life Sciences Ltd | United Kingdom | - | - |
COVIDSHIELD TECHNOLOGIES PRIVATE LIMITED | Maharashtra | 2019 | ₹ 7.5 Cr |
SERUM INSTITUTE VACCINES PRIVATE LIMITED | Maharashtra | 2021 | ₹ 113.3 Cr |
SERUM LIFECARE FOUNDATION | Maharashtra | 2023 | ₹ 0.0 |
Serum Global FZCO | United Arab Emirates | - | - |
Serum Middle East Holdings FZCO | United Arab Emirates | - | - |
Diamond Worldwide Finance Ltd | United Kingdom | - | - |
The incorporation date of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 22 May, 1984
The authorized share capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 55.0 Cr.
The paid-up capital of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is INR ₹ 4.8 Cr.
The registered address of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is 212/2 OFF SOLI POONAWALLA ROAD, HADAPSAR PUNE Pune Maharashtra - 411028
The CIN number of SERUM INSTITUTE OF INDIA PRIVATE LIMITED is U80903PN1984PTC032945.